Programme 11 February
09:30–09:45 Opening of Norway Life Science 2025
Welcome
- Svein St?len, Rector, University of Oslo
- Eirik Lae Solberg, Governing Mayor of Oslo
Hosts
- Carl Henrik G?rbitz, Director, UiO:Life Science, University of Oslo
- Christine Wergeland S?rbye CEO, Oslo Science City
Photo of Lae Solberg by Sturlason.
09:45–10:40 From Health Data Access to Value and Groundbreaking Research - Part 1
- Stefan Woxstr?m, Senior Vice President Europe and Canada, AstraZeneca
This session will be held in Norwegian, with translation to English available for non-Norwegian speakers.
- Torgeir Micaelsen, State Secretary, Ministry of Digitalisation and Public Governance (Labour Party):
Digitalisering, KI og bruk av helsedata som drivkrefter for bedre helsetjenester, fremragende forskning og ny helsen?ring
Paneldiskusjon: Bruk av helsedata i utviklingen av morgendagens robuste helsevesen
- Bj?rn Atle Bj?rnbeth, CEO, Oslo University Hospital
- Guri R?rtveit, Director General, Norwegian Institute of Public Health (FHI)
-
Wenche P. Dehli, Municipal Director, City Council Department for Health and Care, Trondheim Municipality
- Mariann Hornnes, Director General of Health, Norwegian Directorate of Health (Helsedirektoratet)
-
Chairs: Camilla Stoltenberg, CEO, Norce & Per Morten Sandset, Vice-Rector, University of Oslo and Head of HelseOmsorg21-r?det
Photo of Micaelsen by Torbj?rn Tandberg.
10:40–11:05 Break
11:05–12:00 From Health Data Access to Value and Groundbreaking Research - Part 2
This session will be held in Norwegian, with translation to English available for non-Norwegian speakers.
- Tone Varslot Stave, Head of health, Innovation Norway and Erik Jakobsen, Partner, Menon Economics:
Nullpunktsanalyse for eksportsatsing helse - overordnet presentasjon av Menons rapport med n?kkeltall for helseindustrien - Ole Andreassen, Professor & Director Centre of Precision Psychiatry, University of Oslo
Paneldiskusjon: N?dvendige tiltak for ? n? nasjonale ambisjoner
- Erna Solberg, Leader, Conservative Party
- Cathrine Thomassen, General Director, GE HealthCare
- Ingrid Teigland Akay, Managing Partner, Hadean Ventures
- Kjetil Taskén, Head Institute for Cancer Research, Oslo University Hospital & Professor University of Oslo
Chair: Ishita Barua, Chief Health AI Officer, Livv Health
Foto Erna Solberg: Hans Kristian Thorbj?rnsen.
12:00–13:00 Lunch
13:00-14:00 Health data and AI: Solutions for a better society
-
Timothy M. Miller, Vice President, Enterprise Science & Innovation, Thermo Fisher Scientific
-
Erwin B?ttinger, Director, Wyss Center
-
Patrick Schwab, Senior Director of Machine Learning and Artificial Intelligence, GSK
14:00–14:15 Break
14:15–15:30 Parallel Sessions
AI and drug design – precision tools for the largest global challenges
Scientists in the academic forefront will discuss how AI can be used for drug design to predict structure and effect.
- Use and design of antimicrobial peptides as antimicrobials to fight antibiotic resistant pathogens – possibilities and challenges
Morten Kjos, Associate Professor, The Norwegian University of Life Sciences - Using natural bacteriophages to control the bacterial infection pressure in aquaculture
Cyril Franzen, R&D Operations Manager, ACD Pharma - AI-driven biological screening
Alexander Johannes Stasik, Research Scientist, SINTEF Digital - Cortex AI: Advancing Drug Discovery for Life Extension and Beyond
Ivan de Weber, CEO, Cortex Discovery
Chair: Timothy M Miller, Vice President, Enterprise Science & Innovation, Thermo Fisher Scientific
Event organizer: Norwegian University of Life Sciences, SINTEF and The Life Science Cluster
Using register data and RWE to improve population health – how can Norway excel?
-
Real-World Evidence on Pharmaceuticals for Regulatory Purpose in the EU – Capitalizing on Norwegian health registry data in large European initiatives
Hedvig Nordeng, Professor, University of Oslo -
Risk stratification with the ACG System using data from Norwegian health registries
Kjartan Sarheim Anthun, Senior Research Scientist, SINTEF -
European Health Data Space – a stealth revolution
Richard Bergstr?m, Vice President European Affairs, IQVIA -
HPV vaccination – how Norwegian and Nordic registry data can impact public health and support HPV-related cancer elimination globally
Stina Salomonsson, Outcome Research Executive Director, MSD
Chair: Erwin B?ttinger, Director, Wyss Center
Event organizer: Oslo Cancer Cluster, SINTEF, LMI and The Life Science Cluster
Implementation of AI – ethics, organization and trust
What happens when AI is implemented in practice?
- Injecting knowledge in machine learning to increase trust in algorithms by health professionals and patients
Arnoldo Frigessi, Professor, University of Oslo and Director Centre of Excellence Integreat - What is right for ‘this’ patient? Autonomy, trust and transparency in the era of medical AI Anna Smajdor, Professor, University of Oslo
-
Intelligent Resource Planning at Lovisenberg Diaconal Hospital - An Example of How AI Drives Value Creation in Norwegian Hospitals Olav Willumsen Haug?, CEO, Deep Insight
-
Making of Effective AI in Healthcare through Infrastructure and Process Reconfigurations
Alexander Kempton, Associate Professor, University of Oslo
Chair: Nis Johannsen, Head of Digital Innovation, South-Eastern Norway Regional Authority
Event organizer: Norway Health Tech and Integreat
15:30–15:45 Break
15:45-16:30 Health data and AI: Challenges and bottlenecks
Speakers
-
Kristian Hveem, Professor Norwegian University of Science and Technology & HUNT
-
Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation
- Helga M. Br?gger, Senior Scientist, DNV
-
Kristine B?r?e, Professor, University of Oslo
Chair: Ishita Barua, Chief Health AI Officer, Livv Health
17:30-19:00 Reception Oslo City Hall
The doors open at 16:45. The event starts at 17:30